Pancreatic Cancer: Is SBRT or ChemoRT Better Before Surgery? M. Alexander Otto, MMSc-PA

https://www.medscape.com/viewarticle/pancreatic-cancer-sbrt-or-chemort-better-before-surgery-2026a10010o7?src= BOSTON — What type of neoadjuvant therapy is best for patients with resectable, borderline, or locally advanced pancreatic ductal adenocarcinoma (PDAC)? While neoadjuvant therapy has become more common, the optimal type and duration of treatment remain unclear, explained William Hall, MD, radiation oncologist at the Medical College of Wisconsin in Milwaukee. American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting https://www.medscape.com/c25/p14/american-society-radiation-oncology-astro-2026-annual-2026a1000rs5